IADR Abstract Archives

Molybdenum ion inhibits the production of volatile sulfur compounds

Objectives: Oral malodor is mainly caused by the production of volatile sulfur compounds (VSC), such as hydrogen sulfide (H2S) and methyl mercaptan. Some metals including zinc and copper have been shown to inhibit the VSC production. In this study, San-Roku-Go®, which is a healthy beverage containing several kinds of metal ions extracted from biotite, was evaluated for inhibitory effect on the production of VSC. The inhibitory effect of molybdenum solved in San-Roku-Go® was further examined.

Methods: The kind and concentration of metal ions solved in San-Roku-Go®, which was purchased from Mirai Energy Co., Kofu, Japan, was determined using particle-induced X-ray emission analysis. The inhibitory effect of the detected metals on VSC production was quantitatively examined by spectrophotometric assay and gas chromatography analysis, where the recombinant L-cysteine desulfhydrase of Streptococcus anginosus and L-methionine-α-deamino-γ-mercaptomethane-lyase of Porphyromonas gingivalis were used for production of H2S and methyl mercaptan, respectively. In in vivo studies, VSC from oral cavity of volunteers was measured using gas chromatography before and after rinsing with molybdenum-containing water.

Results: San-Roku-Go® has an inhibitory effect on H2S production at a dose-dependent manner. Of 13 metals solved in the solution, molybdenum was one of the most effective metals for inhibition of H2S production. In addition, the production of methyl mercaptan was reduced by the metal. The inhibition was due to result of the high affinity of molybdenum for sulphide anions (S2– and CH3S). The inhibitory effect of molybdenum on the VSC production was also confirmed using human volunteers.

Conclusion: Both in vitro and in vivo studies demonstrated that molybdenum has an inhibitory effect on VSC production, suggesting that this metal is useful for treatment of halitosis.


IADR/AADR/CADR General Session
2009 IADR/AADR/CADR General Session (Miami, Florida)
Miami, Florida
2009
2197
Pharmacology, Therapeutics, & Toxicology
  • Ito, Shuntaro  ( Iwate Medical University, Morioka, N/A, Japan )
  • Yoshida, Yasuo  ( Iwate Medical University, Morioka, N/A, Japan )
  • Sasaki, Takako  ( Iwate Medical University, Morioka, N/A, Japan )
  • Kunimatu, Kazushi  ( Iwate Medical University, Morioka, N/A, Japan )
  • Kato, Hirohisa  ( Iwate Medical University, Morioka, N/A, Japan )
  • Poster Session
    Oral Pharmacology and Therapeutics
    04/03/2009